It is important that treatment decisions be individualized ... Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.

This information could help your doctor choose the right treatment ... Just as dermatomyositis can affect the heart muscle, it can also affect lung tissue, causing interstitial lung disease.

The median time from treatment to RILD development was 1.7 months. Patients were classified as having RILD if both rituximab ...

Our collaborative nature ensures you have an individualized treatment ... can present as ILD too. For patients with connective tissue disorders (CTD) and ILDs (e.g., Rheumatoid arthritis, Scleroderma, ...

we can eventually develop genetic interventional approaches to treatment. Diffuse interstitial lung disease causes major morbidity and mortality due to lung injury and fibrosis. If we can identify ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

With ILD, the interstitium becomes stiff and thick, making it harder to move air in and out of your lungs. Classifying ILDs helps healthcare providers identify the cause and determine the most ...

Pleurisy, which is inflammation in the lining of your lungs (pleura) that causes pain when you breathe, doesn't always need treatment. But you should always see a doctor if you have chest pain ...

Q2 2024 Earnings Call Transcript November 12, 2024 Operator: Good day and thank you for standing by. Welcome to the Roivant ...

There are four main approaches to treatment—psychotherapy, antidepressant medications, neuromodulation, and lifestyle measures—and all address different facets of the disorder.

Good day and thank you for standing by. Welcome to the Roivant second-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I ...